FTC sues important pharmacy gain professionals over insulin rates The company brought action versus Caremark, Categorical Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating procedures “artificially inflated” the list cost of daily life-conserving insulin prescription drugs. Before this summer season, the firm held lengthy negotiations with Steward over https://dave-s-hot-chicken-nutrit08407.digitollblog.com/30428373/everything-about-healthcare-news